AXL and hepatocellular carcinoma: AXL was identified as a downstream effector of TGF-β and modulates expression of TGF-β/SMAD-dependent target genes involved in cell migration in hepatocellular carcinoma (Bauer et al., 2012; Lee et al., 2014; Reichl et al., 2015).